Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor targeted Tnf-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor

Tumor targeted Tnf-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor

US Patent 9815882 · Granted Nov 14, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mesothelin-targeted trail trimer2024
Mesothelin-targeted trail trimer2024
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2019
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2019
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2018
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2018
Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods2018
Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods2018
Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucl2015
Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucl2015